DNA tests have potential to transform next 70 years of NHS care, experts say

July 9, 2018 by Euan Wemyss, University of Aberdeen

Patients in Scotland could benefit from a revolution in personalised healthcare, thanks to major investments in gene sequencing technology.

Researchers say pioneering techniques that can sequence a person's entire genetic make-up in under three days have the potential to transform patient care in the coming decades.

The setting up of two cutting-edge centres for sequencing, in Edinburgh and Glasgow, and the contribution of NHS staff from across Scotland, have laid the foundations that will make the transformation possible.

Work carried out by the Scottish Genomes Partnership, a collaboration led by the Universities of Edinburgh, Glasgow, Aberdeen and Dundee and NHS Scotland, has given researchers unprecedented access to sequencing technologies.

Findings from the project are already helping to improve diagnoses of in the Scottish NHS, as well as advancing the understanding of rare and common diseases including cancer.

More than 400 NHS Scotland patients and their families have now had their entire genetic make-up decoded under the scheme. NHS Scotland Regional Genetics Services have identified sufficient patients with rare inherited conditions to allocate the remainder of the 1,000 genomes available in Scotland as part of the 100,000 Genomes Project.

Professor Tim Aitman, Director of the Centre of Genomic and Experimental Medicine at the University of Edinburgh, is Co-Chair of the Scottish Genomes Partnership.

He said: "As the NHS turns 70, it is the perfect opportunity for the Scottish Genomes Partnership to highlight its hope for the future through the successful between four of Scotland's medical schools, the NHS Scotland Genetics and Laboratory services and Genomics England.

"This technology offers one of the biggest opportunities in today's NHS, delivering precise molecular information that is changing the management of diseases. It could also ultimately enable prevention of diseases. We look forward to working with participants and funders to deliver the next phase of genomic medicine to the people of Scotland."

Professor Andrew Biankin, Director of the Wolfson Wohl Cancer Research Centre at the University of Glasgow and Co-Chair of the Scottish Genomes Partnership, said: "Genomic testing allows us to start predicting which therapies will work best for an individual cancer patient, improving outcomes whilst minimising side-effects and cost. The NHS is optimally positioned to lead in the development and implementation of precision medicine strategies for cancer."

The Scottish Genomes Partnership has received funding from NHS Scotland, the Scottish Government and the UK Medical Research Council. It is collaborating with Genomics England as part of the 100,000 Genomes Project.

Lead clinician for the NHS Scotland Genetics Consortium and lead clinical geneticist for the Scottish Genomes Partnership, Professor Zosia Miedzybrodzka of the University of Aberdeen, said: "NHS Scotland scientists and clinicians will be working over the next year to turn the complex DNA sequence data we have collected already into test results that can make a real difference to the lives of patients and their families."

Fiona Murphy, Director of the NHS National Services Division, said: "Innovation has driven huge changes in the NHS over the past 70 years with new technologies bringing benefits to all patients. Genomics will be central to future medical advances and it is fantastic to be part of the SGP leading a new wave of innovation in the NHS in Scotland."

Explore further: Gene study to shed light on how some people stay sharp in old age

Related Stories

Gene study to shed light on how some people stay sharp in old age

June 6, 2016
More than one thousand people have had their entire genetic make-up decoded as part of a long-term study to gain insight into why some people's brains age better than others.

Scotland launches world's first national atlas of palliative care

September 23, 2016
The first Scottish Atlas of Palliative Care has been by University of Glasgow academics at a major palliative care conference in Edinburgh.

'Unacceptable' cancer treatment waiting times condemned as Scottish targets missed again

March 30, 2017
Waiting times for cancer patients in Scotland have been described as 'unacceptable' after new figures show that a key target has been missed for the fourth year in a row.

Recommended for you

Analytical tool predicts genes that can cause disease by producing altered proteins

July 19, 2018
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international ...

Childhood stress leaves lasting mark on genes

July 18, 2018
Kids who experience severe stress are more likely to develop a host of physical and mental health problems by the time they reach adulthood, including anxiety, depression and mood disorders. But how does early life stress ...

Study shows DNA methylation related to liver disease among obese patients

July 18, 2018
DNA methylation is a molecular process that helps enable our bodies to repair themselves, fight infection, get rid of environmental toxins, and even to think. But sometimes this process goes awry.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

World's largest study on allergic rhinitis reveals new risk genes

July 17, 2018
An international team of scientists led by Helmholtz Zentrum München and University of Copenhagen has presented the largest study so far on allergic rhinitis in the journal Nature Genetics. The data of nearly 900,000 participants ...

New platform poised to be next generation of genetic medicines

July 16, 2018
A City of Hope scientist has discovered a gene-editing technology that could efficiently and accurately correct the genetic defects that underlie certain diseases, positioning the new tool as the basis for the next generation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.